Brendan Kelley, MD
Neurology · Columbus, OHNPI 1578672440
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $44,039 of the $49,500 with a category attached, or 89.0%. 4 manufacturers reported payments, led by Lilly USA, LLC at 52.6% of the total.
Across 54 payments — averaging $916.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$26K
- Eisai Inc.$9K
- Novo Nordisk$8K
- Eli Lilly$7K
Across 68 payments — averaging $12,211 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$540K
- Eli Lilly$264K
- Genentech, Inc.$26K
What the payments were for
- Consulting fees$44,03989%
- Travel & lodging$3,4177%
- Food & beverage$1,9374%
- Education$1080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 30 | $26,045 |
| Eisai Inc. | 11 | $8,757 |
| Novo Nordisk | 6 | $8,150 |
| Eli Lilly | 7 | $6,548 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$49,500 in reported general payments places this provider in the 85th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Galantamine ErGalantamine Hbr | 44 | $6,195 |
| Memantine Hcl | 121 | $5,677 |
| Rivastigmine | 20 | $3,969 |
| Donepezil Hcl | 270 | $3,428 |
| Memantine Hcl ErMemantine Hcl | 22 | $3,014 |
| Bupropion XlBupropion Hcl | 26 | $655 |
| Trazodone Hcl | 31 | $374 |
| Sertraline Hcl | 54 | $291 |
| Duloxetine Hcl | 14 | $211 |
| Clonazepam | 11 | $146 |
| Escitalopram Oxalate | 18 | $132 |
| Buspirone Hcl | 12 | $67 |
| Lorazepam | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Other neurology in Columbus
- Kenneth MankowskiColumbus$1.4M
- Aaron BosterColumbus$1.2M
- Jacqueline NicholasColumbus$743K
- Geoffrey EubankColumbus$508K
- Jerry MendellColumbus$315K
- Andrew SmithColumbus$254K
- Douglas ScharreColumbus$191K
- Aristide MerolaColumbus$133K
- Miriam FreimerColumbus$105K
- Allison JordanColumbus$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.